Hyperlipoproteinemia medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Hardik Patel (talk | contribs) |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Medical Therapy== | ==Medical Therapy== | ||
===[[Hyperlipidemia medical therapy in adults | Medical Therapy in Adults]]=== | |||
===[[Hyperlipidemia NCEP recommendations for drug therapy of high-risk hyperlipidemia in children and adolescents | Medical Therapy in Children and Adolescents]]=== | |||
* [[Hyperlipidemia statins in children and adolescents with hyperlipidemia | Statins]] | * [[Hyperlipidemia statins in children and adolescents with hyperlipidemia | Statins]] | ||
* [[Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents | Adjuvant therapies]] | * [[Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents | Adjuvant therapies]] | ||
Revision as of 14:57, 26 October 2012
|
Lipoprotein Disorders Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]